Prothena Corporation PLC
NASDAQ:PRTA
Prothena Corporation PLC
NASDAQ:PRTA
Price:
22.93 USD
4.04%
Market Closed
Updated:
May 4, 2024
Prothena Corporation PLC
Operating Income
|
Prothena Corporation PLC
Operating Income Peer Comparison
Comparables:
ALKS
AMRN
M
MURA
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Operating Income
-$191m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-17%
|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Operating Income
$420.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
28%
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Operating Income
-$26m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
25%
|
CAGR 10-Years
16%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Operating Income
-$196.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Prothena Corporation PLC's Operating Income?
Operating Income
-191m
USD
-191m
USD
Based on the financial report for Dec 31, 2023, Prothena Corporation PLC's Operating Income amounts to -191m USD.
What is Prothena Corporation PLC's Operating Income growth rate?
Operating Income CAGR 10Y
-17%
-17%
Over the last year, the Operating Income growth was -45%. The average annual Operating Income growth rates for Prothena Corporation PLC have been -19% over the past three years , -6% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
